1. Hu, M. C.; Shiizaki, K.; Kuro-o, M.; Moe, O. W., Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annual review of physiology 2013, 75, 503-33.
2. Chen, G.; Liu, Y.; Goetz, R.; Fu, L.; Jayaraman, S.; Hu, M. C.; Moe, O. W.; Liang, G.; Li, X.; Mohammadi, M., α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 2018, 553 (7689), 461-466.
3. Kuro-o, M.; Matsumura, Y.; Aizawa, H.; Kawaguchi, H.; Suga, T.; Utsugi, T.; Ohyama, Y.; Kurabayashi, M.; Kaname, T.; Kume, E.; Iwasaki, H.; Iida, A.; Shiraki-Iida, T.; Nishikawa, S.; Nagai, R.; Nabeshima, Y. I., Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390 (6655), 45-51.
4. Kuro, O. M.; Moe, O. W., FGF23-αKlotho as a paradigm for a kidney-bone network. Bone 2017, 100, 4-18.
5. Lindberg, K.; Amin, R.; Moe, O. W.; Hu, M. C.; Erben, R. G.; ?stman Wernerson, A.; Lanske, B.; Olauson, H.; Larsson, T. E., The kidney is the principal organ mediating klotho effects. Journal of the American Society of Nephrology : JASN 2014, 25 (10), 2169-75.
6. Mu?oz-Casta?eda, J. R.; Herencia, C.; Pendón-Ruiz de Mier, M. V.; Rodriguez-Ortiz, M. E.; Diaz-Tocados, J. M.; Vergara, N.; Martínez-Moreno, J. M.; Salmerón, M. D.; Richards, W. G.; Felsenfeld, A.; Kuro, O. M.; Almadén, Y.; Rodríguez, M., Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2017, 31 (9), 3858-3867.
7. Shikida, Y.; Mizobuchi, M.; Yoshitake, O.; Kato, T.; Ogata, H.; Koiwa, F.; Honda, H., Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2021, 25 (3), 331-340.
8. Rodríguez-Ortiz, M. E.; Díaz-Tocados, J. M.; Mu?oz-Casta?eda, J. R.; Herencia, C.; Pineda, C.; Martínez-Moreno, J. M.; Montes de Oca, A.; López-Baltanás, R.; Alcalá-Díaz, J.; Ortiz, A.; Aguilera-Tejero, E.; Felsenfeld, A.; Rodríguez, M.; Almadén, Y., Inflammation both increases and causes resistance to FGF23 in normal and uremic rats. Clinical science (London, England : 1979) 2020, 134 (1), 15-32.
9. Cui, W.; Leng, B.; Wang, G., Klotho protein inhibits H(2)O(2)-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways. Canadian journal of physiology and pharmacology 2019, 97 (5), 370-376.
10. Norris, K. C.; Olabisi, O.; Barnett, M. E.; Meng, Y. X.; Martins, D.; Obialo, C.; Lee, J. E.; Nicholas, S. B., The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. International journal of environmental research and public health 2018, 15 (12).
11. Leifheit-Nestler, M.; Haffner, D., Paracrine Effects of FGF23 on the Heart. Frontiers in endocrinology 2018, 9, 278.
12. Agoro, R.; Montagna, A.; Goetz, R.; Aligbe, O.; Singh, G.; Coe, L. M.; Mohammadi, M.; Rivella, S.; Sitara, D., Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018, 32 (7), 3752-3764.
13. Singh, S.; Grabner, A.; Yanucil, C.; Schramm, K.; Czaya, B.; Krick, S.; Czaja, M. J.; Bartz, R.; Abraham, R.; Di Marco, G. S.; Brand, M.; Wolf, M.; Faul, C., Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney international 2016, 90 (5), 985-996.
14. Pescatore, L. A.; Gamarra, L. F.; Liberman, M., Multifaceted Mechanisms of Vascular Calcification in Aging. Arteriosclerosis, thrombosis, and vascular biology 2019, 39 (7), 1307-1316.
15. Donate-Correa, J.; Martín-Nú?ez, E.; Hernández-Carballo, C.; Ferri, C.; Tagua, V. G.; Delgado-Molinos, A.; López-Castillo, á.; Rodríguez-Ramos, S.; Cerro-López, P.; López-Tarruella, V. C.; Felipe-García, R.; Arévalo-Gomez, M. A.; Pérez-Delgado, N.; Mora-Fernández, C.; Navarro-González, J. F., Fibroblast growth factor 23 expression in human calcified vascular tissues. Aging 2019, 11 (18), 7899-7913.
16. Jimbo, R.; Kawakami-Mori, F.; Mu, S.; Hirohama, D.; Majtan, B.; Shimizu, Y.; Yatomi, Y.; Fukumoto, S.; Fujita, T.; Shimosawa, T., Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney international 2014, 85 (5), 1103-11.
17. B?ckmann, I.; Lischka, J.; Richter, B.; Deppe, J.; Rahn, A.; Fischer, D. C.; Heineke, J.; Haffner, D.; Leifheit-Nestler, M., FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis. International journal of molecular sciences 2019, 20 (18).
18. Zhou, X.; Chen, K.; Wang, Y.; Schuman, M.; Lei, H.; Sun, Z., Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. Journal of the American Society of Nephrology : JASN 2016, 27 (6), 1765-76.
19. Pi, M.; Ye, R.; Han, X.; Armstrong, B.; Liu, X.; Chen, Y.; Sun, Y.; Quarles, L. D., Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II. Scientific reports 2018, 8 (1), 12398.
20. Ding, J.; Tang, Q.; Luo, B.; Zhang, L.; Lin, L.; Han, L.; Hao, M.; Li, M.; Yu, L.; Li, M., Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway. European journal of pharmacology 2019, 859, 172549.
21. Han, X.; Cai, C.; Xiao, Z.; Quarles, L. D., FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. Journal of molecular and cellular cardiology 2020, 138, 66-74.
22. Kuga, K.; Kusakari, Y.; Uesugi, K.; Semba, K.; Urashima, T.; Akaike, T.; Minamisawa, S., Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1. PloS one 2020, 15 (4), e0231905.
23. Huang, S. Y.; Chen, Y. C.; Kao, Y. H.; Hsieh, M. H.; Lin, Y. K.; Chung, C. C.; Lee, T. I.; Tsai, W. C.; Chen, S. A.; Chen, Y. J., Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes. Oncotarget 2016, 7 (43), 69231-69242.
24. Navarro-García, J. A.; Delgado, C.; Fernández-Velasco, M.; Val-Blasco, A.; Rodríguez-Sánchez, E.; Aceves-Ripoll, J.; Gómez-Hurtado, N.; Bada-Bosch, T.; Mérida-Herrero, E.; Hernández, E.; Praga, M.; Salguero, R.; Solís, J.; Arribas, F.; Delgado, J. F.; Bueno, H.; Kuro, O. M.; Ruilope, L. M.; Ruiz-Hurtado, G., Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019, 34 (11), 1864-1875.
25. Graves, J. M.; Vallejo, J. A.; Hamill, C. S.; Wang, D.; Ahuja, R.; Patel, S.; Faul, C.; Wacker, M. J., Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner. American journal of physiology. Heart and circulatory physiology 2021, 320 (6), H2283-h2294.
